Metraipolis › archive › dc_fa7bb6644ba8
Disrupting Viral Persistence: CRISPR/Cas9-Based Strategies for Hepatitis B and C Treatment, and Challenges — Europe PMC PMID:41503845
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41503845
- DOI
- 10.1111/jcmm.70986
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T03:49:14.264Z
- SHA-256 of the archived text
bd3a03d02e236077cf14d9ebf8d4dcc19b7908b68d58326436e3972c2129c59f- Stable URL of this page
https://metraipolis.com/documento/dc_fa7bb6644ba8
How to cite
Disrupting Viral Persistence: CRISPR/Cas9-Based Strategies for Hepatitis B and C Treatment, and Challenges — Europe PMC PMID:41503845 — Europe PMC (en), https://europepmc.org/article/MED/41503845 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fa7bb6644ba8 (Metraipolis archive dc_fa7bb6644ba8, sha256 bd3a03d02e236077cf14d9ebf8d4dcc19b7908b68d58326436e3972c2129c59f)
BibTeX
@misc{dcfa7bb6644ba8,
title = {Disrupting Viral Persistence: CRISPR/Cas9-Based Strategies for Hepatitis B and C Treatment, and Challenges — Europe PMC PMID:41503845},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41503845},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fa7bb6644ba8; sha256 bd3a03d02e236077cf14d9ebf8d4dcc19b7908b68d58326436e3972c2129c59f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41503845. Agents can read the archived copy with the MCP tool read_document.